引用次数
引用: 31,998
H-指数: 82
I10-指数 : 141
出版物: 289
Class II MHC transcriptional mutants are defective in higher order complex formation.
J M Boss , J L Riley
Journal of Immunology 151 ( 12) 6942 -6953
32
1993
Intrinsic resistance to T cell infection with HIV type 1 induced by CD28 costimulation.
C H June , B L Levine , J L Riley , W Bernstein
Journal of Immunology 158 ( 11) 5545 -5553
79
1997
Protease treatment of nuclear extracts distinguishes between class II MHC X1 box DNA-binding proteins in wild-type and class II-deficient B cells.
J M Boss , J L Riley , S L Hasegawa , J H Sloan
Journal of Immunology 150 ( 5) 1781 -1793
38
1993
Chronic Virus Infection Enforces Demethylation of the Locus that Encodes PD-1 in Antigen-Specific CD8+ T Cells
Ben Youngblood , Kenneth J Oestreich , Sang-Jun Ha , Jaikumar Duraiswamy
Immunity 35 ( 3) 400 -412
251
2011
Large-Scale Production of CD4+ T Cells from HIV-1-Infected Donors After CD3/CD28 Costimulation*
BRUCE L. LEVINE , JULIO COTTE , CAROLYNN C. SMALL , RICHARD G. CARROLL
Journal of hematotherapy 7 ( 5) 437 -448
122
1998
MHC class II gene silencing in trophoblast cells is caused by inhibition of CIITA expression.
ANN C. MORRIS , JAMES L. RILEY , WILLIAM H. FLEMING , JEREMY M. BOSS
American Journal of Reproductive Immunology 40 ( 6) 385 -394
49
1998
Grand Challenges for Biological and Environmental Research: A Long-Term Vision
A. Arkin , N. Baliga , J. Braam , G. Church
4
2010
ACTIVATION OF CLASS-II MHC GENES
JL RILEY , JM BOSS
JOURNAL OF CELLULAR BIOCHEMISTRY 52 -52
1994
RECORDS OF THE AUCKLAND MUSEUM
R NEICH , BW HAYWARD , AB STEPHENSON , MS MORLEY
Records of the Auckland Museum 35
1998
RELATIVE SAFETY OF T CELLS AND HEMATOPOIETIC STEM CELLS
JAMES L RILEY , CARL H JUNE
Concepts in Genetic Medicine 193 -193
2008
Ultrasensitive antigen density discrimination by synNotch.
James L Riley , Divanshu Shukla
Cell Research 1 -2
2021
Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation
Marc Beyer , Yasser Thabet , Roman-Ulrich Müller , Timothy Sadlon
Nature Immunology 12 ( 9) 898 -907
150
2011
Are affinity-enhanced T cells the future of HIV therapy?
Angel Varela-Rohena , Bent K Jakobsen , Andrew K Sewell , Carl H June
Hiv Therapy 3 ( 2) 105 -108
1
2009
Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor
Angel Varela-Rohena , Peter E Molloy , Steven M Dunn , Yi Li
Nature Medicine 14 ( 12) 1390 -1395
221
2008
The CD28 signaling pathway regulates glucose metabolism.
Kenneth A Frauwirth , James L Riley , Marian H Harris , Richard V Parry
Immunity 16 ( 6) 769 -777
1,430
2002
Stabilized Human TRIM5α Protects Human T Cells From HIV-1 Infection
Max W Richardson , Lili Guo , Frances Xin , Xiaolu Yang
Molecular Therapy 22 ( 6) 1084 -1095
24
2014
Engineering T Cells to Functionally Cure HIV-1 Infection.
Rachel S Leibman , James L Riley
Molecular Therapy 23 ( 7) 1149 -1159
39
2015
Engineering Artificial Antigen-presenting Cells to Express a Diverse Array of Co-stimulatory Molecules
Megan M Suhoski , Tatiana N Golovina , Nicole A Aqui , Victoria C Tai
Molecular Therapy 15 ( 5) 981 -988
284
2007
Discovery and Engineering of a Therapeutic Interfering Particle (TIP): a combination self-renewing antiviral
Elizabeth J Tanner , Seung-Yong Jung , Joshua Glazier , Cassandra Thompson
bioRxiv 820456
3
2019
Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes
Qunrui Ye , Maria Loisiou , Bruce L Levine , Megan M Suhoski
Journal of Translational Medicine 9 ( 1) 131 -131
53
2011